Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

ABBV-295

A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity

AbbVie · Phase 1 · Active, not recruiting · Enrollment 80

NCT07291232

ArmPopulationDoseWeeksEstimandWeight change
ABBV-295 or Placebo-Group 1Obesity or overweightn/rn/rn/rn/r
ABBV-295 or Placebo-Group 2Obesity or overweightn/rn/rn/rn/r
ABBV-295 or Placebo-Group 3Obesity or overweightn/rn/rn/rn/r
ABBV-295 or Placebo-Group 3 ExtensionObesity or overweightn/rn/rn/rn/r
ABBV-295 or Placebo-Group 4Obesity or overweightn/rn/rn/rn/r
ABBV-295 or Placebo-Group 4 ExtensionObesity or overweightn/rn/rn/rn/r
ABBV-295 or Placebo-Group 5Obesity or overweightn/rn/rn/rn/r
ABBV-295 or Placebo-Group 6Obesity or overweightn/rn/rn/rn/r